Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

Gordon Research Conferences

Events
GORDON CONFERENCESgate2brain

Gate2Brain is in Oxnard, on California’s south coast, USA, attending the 2022 Gordon Research Conferences, “Chemistry and Biology of Peptides Conference”.

This conference highlights the diversity of peptide science. A very enriching conference where we have been engaging in discussions regarding discoveries, challenges and advances in the design, synthesis, characterization and translation of peptides.

Our CEO, Meritxell Teixidó, has had the great opportunity to explain our project of “Gate2Brain opening the Gate to Cure CNS Diseases”

For Gate2Brain these are some weeks of intense business trips , but what makes these trips enjoyable and rewarding is the confluence with amazing professionals and scientists and the opportunity to make wonderful human encounters.

Always exchanging ideas and creating new alliances to bring medicines beyond barriers!

November 3, 2022/by noticias
Tags: gordonresearchconferences, mediciensbeyondbarriers, peptides
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2022/11/Post-de-Facebook-Estamos-contratando-personal-Empresarial-Informativo-Rojo-y-blanco.gif 788 940 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2022-11-03 11:41:252022-11-03 11:41:25Gordon Research Conferences
You might also like
Amphiphilic Polymeric Nanoparticles Modified with Protease-Resistant Peptide Shuttle for the Delivery of SN-38 in Diffuse Intrinsic Pontine Glioma
Validation of Gate2Brain Technology in the Transport of Antibodies to the Brain Opens the Avenue of the Next Generation of CNS Therapeutics with Improved Delivery to the Brain
17th China International Peptide Academic Symposium17th China International Peptide Academic Symposium
Imitating nature to improve health
Tides 2023G2BTides USA 2023 Oligonucleotide & Peptide Therapeutic
New Trends in Brain Shuttle Peptides
Back to Work with Peptides
Gate2Brain: the startup that delivers drugs to the brain to treat childhood cancer with no cure

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34
  • 4YFN 2025March 6, 2025 - 19:45
  • Keystone Symposia on Drug Delivery to the Brain: Emerging ModalitiesFebruary 21, 2025 - 11:10
  • Gate2Brain at ACCELERATE 2025: A Decade of Impact and Future Innovations in Pediatric OncologyFebruary 20, 2025 - 10:19

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
G2B joined the Grit International Female AcceleratorGrit International Female Accelerator!Grit International Female Accelerator2 year anniversaryGate2BrainGate2Brain 2 year highlights at a glance
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}